[1] Sala E,
Rockall AG,
Freeman SJ,
Mitchell DG,
Reinhold C.The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know.
Radiology.
2013; 266(3):717-40
[2] Shah SH,
Jagannathan JP,
Krajewski K,
O´Regan KN,
Ramaiya NH.
Uterine sarcomas: then and now.
Am J Roentgenol.
2012; 199(1):213-23
[3] Bharwani N.
et al.
MRI appearances of uterine malignant mixed müllerian tumors.
Am J Roentgenol.
2010; 195(5):1268-75
[4] Beddy P,
O´Neill AC,
Yamamoto AK,
Addley HC,
Reinold C,
Sala E.
FIGO staging system for endometrial cancer: added benefits of MR imaging.
Radiographics.
2012; 32(1):241-54
[5] D´Angelo E,
Prat J.
Uterine sarcomas: a review.
Gynecol Oncol.
2010; 116(1):131-9.
[6] Teo SY,
Babagbemi KT,
Peters HE,
Mortele KJ. Primary malignant mixed mullerian tumor of the uterus: findings on sonography,
CT,
and gadolinium-enhanced MRI.
AJR.
2008;191(1):278-83.
[7] Sahdey A,
Sohaib SA,
Jacobs I,
Shepherd JH,
Oram DH,
Reznek RH.
MR imaging of uterine sarcomas.
AJR.
2001;177(6):1307-11.
[8] Szklaruk J,
Tamm EP,
Choi H,
Varavithya V.
MR imaging of common and uncommon large pelvic masses.
Radiographics.
2003; 23(2):403-24.
[9] Tirumani SH,
Ojili V,
Shanbhigue AK,
Fasih N,
Ryan JG,
Reinhold C.
Current concepts in the imaging of uterine sarcoma.
Abdom Imaging.
2013;38(2):397-411.
[10] Ferguson SE,
Tornos C,
Hummer A,
Barakat RR,
Soslow RA .
Prognostic features of surgical stage I uterine carcinosarcoma.
Am J Surg Pathol.
2007; 31(11):1653–1661.
[11] Ohguri T,
Aoki T,
Watanabe H,
Nakamura K,
Nakata H,
Matsuura Y,
Kashimura M.
MRI findings including gadolinium-enhanced dynamic studies of malignant,
mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas.
Eur Radiol.
2002;12(11):2737-42.
[12] Genever AV,
Abdi S.
Can MRI predict the diagnosis of endometrial carcinosarcoma? Clin Radiol.
2011;66(7):621-4.
[13] Kato H,
Kanematsu M,
Furui T,
et al.
Carcinosarcoma of the uterus: radiologic–pathologic correlations with magnetic resonance imaging including diffusion-weighted imaging.
Magn Reson Imaging.
2008; 26:1446–1450
[14] Pecorelli S.
Revised FIGO staging for carcinoma of the vulva,
cervix,
and endometrium.
Int J Gynaecol Obstet.
2009;105(2):103–104.
[15] FIGO Committee on Gynecologic Oncology (2009) FIGO staging
for uterine sarcomas.
Int J Gynaecol Obstet 104:179